STX209

STX209 (arbaclofen), a selective GABA-B agonist, is hypothesized to modulate the balance of excitatory to inhibitory neurotransmission, and has shown preliminary evidence of benefit in fragile X syndrome. We evaluated its safety, tolerability, and efficacy in non-syndromic autism spectrum disorders,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of autism and developmental disorders 2014-04, Vol.44 (4), p.958
Hauptverfasser:	Erickson, Craig A, Veenstra-Vanderweele, Jeremy M, Melmed, Raun D, McCracken, James T, Ginsberg, Lawrence D, Sikich, Linmarie, Scahill, Lawrence, Cherubini, Maryann, Zarevics, Peter, Walton-Bowen, Karen, Carpenter, Randall L, Bear, Mark F, Wang, Paul P, King, Bryan H
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic drugs Complications and side effects Dosage and administration Drug therapy Patient outcomes Pervasive developmental disorders Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!